These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer's disease patients on 11C-N-methyl-4-piperidyl benzilate--comparison with cerebral blood flow and cerebral glucose metabolism. Yoshida T; Kuwabara Y; Ichiya Y; Sasaki M; Fukumura T; Ichimiya A; Takita M; Ogomori K; Masuda K Ann Nucl Med; 1998 Feb; 12(1):35-42. PubMed ID: 9559960 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease]. Zhang XQ; Min BQ; Ma YC; Yang PJ; Li DP Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):100-2. PubMed ID: 12812674 [TBL] [Abstract][Full Text] [Related]
7. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567 [TBL] [Abstract][Full Text] [Related]
8. Regional cerebral glucose transport and utilization in Alzheimer's disease. Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318 [TBL] [Abstract][Full Text] [Related]
9. FDG PET imaging in patients with pathologically verified dementia. Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505 [TBL] [Abstract][Full Text] [Related]
10. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432 [TBL] [Abstract][Full Text] [Related]
11. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390 [TBL] [Abstract][Full Text] [Related]
13. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity]. Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383 [TBL] [Abstract][Full Text] [Related]
14. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045 [TBL] [Abstract][Full Text] [Related]
15. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263 [TBL] [Abstract][Full Text] [Related]